Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Dual Role of the Innate Immune System in the Effectiveness of mRNA Therapeutics
Аlbert R. Muslimov, Valeriy Tereshchenko, Daniil Shevyrev, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14820-14820
Open Access | Times Cited: 19

Showing 19 citing articles:

mRNA vaccines in the context of cancer treatment: from concept to application
Qiang Fu, Xiaoming Zhao, Jinxia Hu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Development of a minimal PBPK-QSP modeling platform for LNP-mRNA based therapeutics to study tissue disposition and protein expression dynamics
Kenji Miyazawa, Yun Liu, Hojjat Bazzazi
Frontiers in Nanotechnology (2024) Vol. 6
Open Access | Times Cited: 7
Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Unlocking ocular therapy: Harnessing the power of non-coding RNAs
Vahideh Mohammadzadeh, Neda Mostajeran, Mina Shaban, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 98, pp. 105847-105847
Closed Access | Times Cited: 4
DNA and RNA vaccines against tuberculosis: a scoping review of human and animal studies
Alisa Kazakova, Pavel Zhelnov, Roman Yu. Sidorov, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Advancements and challenges in mRNA and ribonucleoprotein-based therapies: From delivery systems to clinical applications
Zohre Eftekhari, Horieh Zohrabi, Akbar Oghalaie, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 3, pp. 102313-102313
Open Access | Times Cited: 3
Advancement in the development of mRNA‐based vaccines for respiratory viruses
Tays Troncoso-Bravo, Mario A. Ramírez, Ricardo A. Loaiza, et al.
Immunology (2024) Vol. 173, Iss. 3, pp. 481-496
Open Access | Times Cited: 3
RNA therapeutics for infectious diseases
Le Minh Tu Phan, Thi Thuy Duong Pham, Van Thai Than
Progress in molecular biology and translational science (2024), pp. 109-132
Closed Access | Times Cited: 1
The candidate anti-tuberculosis mRNA vaccine immunogenicity and reactogenicity dependency on the animal’s sex and the vaccine dose
Vasiliy Reshetnikov, Galina Shepelkova, A.D. Rybakova, et al.
Bulletin of Russian State Medical University (2024), Iss. 2024(5)
Open Access | Times Cited: 1
Effects of Various Poly(A) Tails on Luciferase Expression
Ivan Kukushkin, О. В. Васильева, Dmitry Kunyk, et al.
Biochemistry (Moscow) Supplement Series B Biomedical Chemistry (2024) Vol. 18, Iss. 3, pp. 263-274
Closed Access | Times Cited: 1
A Cap-Optimized mRNA Encoding Multiepitope Antigen ESAT6 Induces Robust Cellular and Humoral Immune Responses Against Mycobacterium tuberculosis
Alena Kozlova, Ildus Pateev, Galina Shepelkova, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1267-1267
Open Access | Times Cited: 1
Unlocking Therapeutic Potential of siRNA-based Drug Delivery System for Treatment of Alzheimer's Disease
Smita Jain, Bharat Bhushan, Ashwini Kumar Mishra, et al.
Journal of Drug Delivery Science and Technology (2024), pp. 106413-106413
Closed Access | Times Cited: 1
Current Progress in the Development of mRNA Vaccines Against Bacterial Infections
А. Н. Хлебникова, Anna Kirshina, N. A. Zakharova, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 13139-13139
Open Access | Times Cited: 1
Identifying Key Drivers of Efficient B Cell Responses: On the Role of T Help, Antigen-Organization, and Toll-like Receptor Stimulation for Generating a Neutralizing Anti-Dengue Virus Response
Jan M. Sobczak, Irena Barkovska, Ina Baļķe, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 661-661
Open Access | Times Cited: 1
Composition of lipid nanoparticles for targeted delivery: application to mRNA therapeutics
О. С. Васильева, Olga V. Zaborova, Bogdan Shmykov, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Impact of untranslated mRNA sequences on immunogenicity of mRNA vaccines against M. tuberculosis in mice
GS Shepelkova, Vasiliy Reshetnikov, VG Avdienko, et al.
Bulletin of Russian State Medical University (2023), Iss. 2023(6)
Open Access | Times Cited: 2
Senolytic Vaccines from the Central and Peripheral Tolerance Perspective
Maria Vasilieva, Rimma O. Shatalova, Kseniia S. Matveeva, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1389-1389
Open Access
Current vaccine candidate of toxoplasmosis
Eden Woldegerima, Fasika GETACHEW, Meseret MISGANAW, et al.
Journal of Life Science and Biomedicine (2024), pp. 54-67
Closed Access
Vliyanie netransliruemyh posledovatel'nostej mRNK na immunogennost' mRNK-vakcin protiv M. tuberculosis u myshej
Galina Shepelkova, Vasiliy Reshetnikov, В. Г. Авдиенко, et al.
Вестник Российского государственного медицинского университета (2023), Iss. 2023(6)
Open Access
Page 1

Scroll to top